Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$191.17 - $325.63 $210,287 - $358,193
1,100 Added 6.75%
17,400 $5.67 Million
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $595,663 - $798,053
-3,700 Reduced 18.5%
16,300 $3.11 Million
Q3 2023

Nov 15, 2023

BUY
$194.33 - $283.97 $58,299 - $85,191
300 Added 1.52%
20,000 $3.98 Million
Q2 2023

Aug 23, 2023

BUY
$223.05 - $302.68 $1.83 Million - $2.48 Million
8,200 Added 71.3%
19,700 $5.62 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $2.02 Million - $2.51 Million
11,500 New
11,500 $2.46 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $5.02 Million - $7.98 Million
25,700 New
25,700 $7.09 Million
Q2 2022

Aug 15, 2022

SELL
$115.91 - $214.48 $1.66 Million - $3.07 Million
-14,300 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$127.96 - $207.36 $396,676 - $642,816
3,100 Added 27.68%
14,300 $2.79 Million
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $2.99 Million - $4.38 Million
-18,100 Reduced 61.77%
11,200 $2.01 Million
Q3 2021

Nov 12, 2021

BUY
$163.99 - $235.57 $1.05 Million - $1.51 Million
6,400 Added 27.95%
29,300 $6.02 Million
Q2 2021

Aug 06, 2021

BUY
$131.45 - $201.49 $1.06 Million - $1.63 Million
8,100 Added 54.73%
22,900 $4.41 Million
Q1 2021

May 14, 2021

BUY
$92.73 - $142.05 $1 Million - $1.53 Million
10,800 Added 270.0%
14,800 $1.82 Million
Q4 2020

Feb 12, 2021

SELL
$67.44 - $103.72 $566,496 - $871,248
-8,400 Reduced 67.74%
4,000 $404,000
Q3 2020

Nov 13, 2020

BUY
$42.79 - $75.8 $34,232 - $60,640
800 Added 6.9%
12,400 $924,000
Q2 2020

Aug 13, 2020

BUY
$27.25 - $47.53 $32,700 - $57,036
1,200 Added 11.54%
11,600 $537,000
Q1 2020

May 11, 2020

BUY
$23.16 - $47.74 $240,864 - $496,496
10,400 New
10,400 $374,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.